Hyperphosphatemia: all 152 studies
Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Tenapanor in Maintenance Hemodialysis PatientsNot yet recruitingNCT07882017
- Phosphate in Acute PancreatitisRecruitingNCT07681050Phase 2
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaRecruitingNCT06933472Phase 3
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaRecruitingNCT06712654Phase 2
- Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaRecruitingNCT06664125Phase 2
- Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis PatientsEnrolling by invitationNCT06406140Phase 2/3
- Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil CapsuleRecruitingNCT06206135
- Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsRecruitingNCT06186934
- Improving Phosphate Control in Children With CKDRecruitingNCT05439980
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT04278404
- Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)RecruitingNCT03573089Not applicable
- Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney DiseaseCompletedNCT05085275Phase 3Results posted
- Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of HyperphosphatemiaCompletedNCT04549597Phase 4Results posted
- Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis PatientsCompletedNCT04046263Phase 4Results posted
- A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HPCompletedNCT03988920Phase 4Results posted
- Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder TherapyCompletedNCT03824587Phase 2/3Results posted
- A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisCompletedNCT03427125Phase 3Results posted
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis PatientsCompletedNCT03079869Phase 4Results posted
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCompletedNCT03001011Phase 3Results posted
- A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With HyperphosphataemiaTerminatedNCT02688764Phase 3Results posted
- An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)CompletedNCT02675998Phase 3Results posted
- A Study of Ferric Citrate to Improve Inflammation and Lipid LevelsTerminatedNCT02661295Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney DiseaseCompletedNCT02151643Phase 2Results posted
- Dose Finding Study to Treat High Phosphate Levels in the Blood.CompletedNCT02081534Phase 2Results posted
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedNCT01976572Phase 1Results posted
- A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850641Phase 3Results posted
- A Phase III Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850602Phase 3Results posted
- A Long-term Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01833494Phase 3Results posted
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 4Results posted
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCompletedNCT01696279Phase 2Results posted
- An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney DiseaseCompletedNCT01574326Phase 2Results posted
- A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on DialysisCompletedNCT01554982Phase 3Results posted
- PA21 Phase II Clinical Study in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01521494Phase 2Results posted
- The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET ScanTerminatedNCT01238588Not applicableResults posted
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on DialysisCompletedNCT01191255Phase 3Results posted
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal DiseaseCompletedNCT01074125Phase 3Results posted
- A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaCompletedNCT01039428Phase 2Results posted
- Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal DiseaseCompletedNCT00967993Results posted
- Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00772382Phase 3Results posted
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis PatientsCompletedNCT00660530Phase 2Results posted
- A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)CompletedNCT00648167Phase 2Results posted
- Long-term Effect of Lanthanum Carbonate on BoneCompletedNCT00557323Results posted
- A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00542815Phase 3Results posted
- A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and DyslipidaemiaCompletedNCT00542386Phase 3Results posted
- A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With HyperphosphatemiaCompletedNCT00506441Phase 3Results posted
- A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With HyperphosphatemiaCompletedNCT00416520Phase 3Results posted
- Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis PatientsCompletedNCT07180069Not applicable
- AP301 Efficacy and Safety in Chinese Dialysis Patients With HyperphosphatemiaCompletedNCT07030595Phase 3
- Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on HemodialysisCompletedNCT05897502Not applicable
- A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia PatientsCompletedNCT05764590Phase 2
- A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on HemodialysisCompletedNCT05699239Phase 2
- Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis PatientsCompletedNCT05577507Phase 4
- av Fistula Patency Loss as a Cause of Fistula Failure and HyperphosphatemiaStatus unknownNCT05569109
- mHealth for Phosphorus Management in CKD.Active, not recruitingNCT05389826Not applicable
- Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis ParticipantsCompletedNCT04922645Phase 4
- Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With HyperphosphatemiaCompletedNCT04789876Not applicable
- Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04771780Phase 3
- Clinical Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04767581Phase 3
- Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04766398Phase 3
- Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal DialysisCompletedNCT04766385Phase 3
- Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney DiseaseCompletedNCT04579315Not applicable
- A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis PatientsCompletedNCT04551300Phase 2
- Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseSuspendedNCT04523727Phase 3
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedNCT04456803Phase 3
- To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate PowderStatus unknownNCT04440696Phase 1/2
- Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum ElectrolytesCompletedNCT04256369
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedNCT03984760Phase 3
- Dose-finding Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864458Phase 2
- Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864445Phase 2
- Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis PatientsCompletedNCT03861247Phase 3
- A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HDCompletedNCT03831607Phase 2
- PA21 Safety and Efficacy in Adult Chinese SubjectsCompletedNCT03644264Phase 3
- Phosphate Microvascular StudyStatus unknownNCT03594539Not applicable
- Velphoro and Impact on the Oral Cavity and Gut MicrobiomeTerminatedNCT03409757
- Low-Phosphate Diet and Fibroblast Growth Factor-23 LevelCompletedNCT03367338Not applicable
- DS2330b Alone and With Sevelamer in Patients on Chronic HemodialysisCompletedNCT03305471Phase 1
- Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on DialysisCompletedNCT03256838Phase 4
- Egg White for Phosphorus Control in Haemodialysis PatientsStatus unknownNCT03236701Not applicable
- Hyperphosphatemia in Children With Chronic Kidney DiseaseStatus unknownNCT03202407Phase 3
- The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing HaemodialysisStatus unknownNCT03163576Phase 4
- Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food ChoicesCompletedNCT03146923Not applicable
- A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisCompletedNCT02965053Phase 1
- Behavioral Management of Phosphorus in Hemodialysis PatientsCompletedNCT02940743Not applicable
- Nicotinic Acid in Hemodialysis Patients With HyperphosphatemiaStatus unknownNCT02836184Phase 4
- Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis PatientsCompletedNCT02755961Not applicable
- Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaCompletedNCT02753894Phase 2
- Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)CompletedNCT02687594
- Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis PatientsCompletedNCT02684643Not applicable
- Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in JapanCompletedNCT02510274Phase 1
- Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5DCompletedNCT02492620Phase 3
- A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing HemodialysisStatus unknownNCT02469467Phase 1/2
- Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and HyperphosphatemiaStatus unknownNCT02237534Phase 4
- Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® GranulesCompletedNCT02027662Phase 2/3
- Effect of Restriction of Foods Containing Phosphorus AdditivesCompletedNCT01965379Not applicable
- Fosrenol Post-marketing Surveillance in JapanCompletedNCT01955876
- Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal DialysisCompletedNCT01903213
- Post-marketing Surveillance of Kiklin Capsules in Hemodialysis PatientsCompletedNCT01901107
- Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With HyperphosphataemiaCompletedNCT01857024
- The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis PatientsCompletedNCT01854437
- A Phase III Study of PA21 in Peritoneal Dialysis Patients With HyperphosphatemiaCompletedNCT01852682Phase 3